Cabozantinib price comparison and medical insurance coverage

Cabozantinib (Cabozantinib) is a targeted drug mainly used to treat various tumors such as advanced renal cancer and thyroid cancer. Although this drug has a certain sales volume in the international market, cabozantinib has not yet been approved for marketing in China. Therefore, if patients need to use this drug, they must purchase it through overseas channels.

Since cabozantinib is not marketed in China, patients cannot purchase the drug directly through regular domestic hospital pharmacies. Currently, domestic patients can only obtain drugs through legal overseas drug import channels or overseas purchasing. Because the original drug of cabozantinib is more expensive in the international market, the price is usually higher. Among the original drugs sold in different regions such as European version, Hong Kong version, Japanese version and Turkish version, the price generally ranges from more than 20,000 yuan to more than 50,000 yuan, which is undoubtedly a considerable treatment cost for patients. Therefore, patients need to carefully weigh the price and treatment effect when purchasing.

In order to reduce the financial burden on patients, generic drugs have become the choice of many patients. Generic versions of cabozantinib are already officially on the market in some countries, such as Laos and Bangladesh, and the price is significantly lower than the original drug. For example, cabozantinib generic drugs in Laos and Bangladesh are available in specifications such as 20mg*90 tablets, 60mg*30 tablets and 80mg*30 tablets. The latest prices range from more than 500 yuan to one to two thousand yuan. The ingredients of generic drugs are basically the same as those of the original drugs, so they have similar guarantees for the treatment effect. For patients, choosing generic drugs can not only save costs, but also effectively complete the treatment.

For patients who need cabozantinib, although it has not yet been launched in China, the drug can be purchased through overseas purchasing agents, international drug platforms and regular drug import channels. When patients choose a purchasing channel, they must ensure that the chosen channel is legal and reliable, and avoid purchasing counterfeit and substandard drugs through informal channels. In addition, patients need to choose the most suitable version of the drug based on their individual treatment needs, drug strength and price. When purchasing, you should also consult a professional doctor to ensure the suitability and safety of the drug. In short, although cabozantinib is more expensive, patients can reduce the economic burden of treatment while ensuring the effectiveness of treatment through the choice of generic drugs.

Reference:https://en.wikipedia.org/wiki/Cabozantinib